What is the official website of Empower Pharmacy ?

The official website of Empower Pharmacy is https://empowerpharmacy.com.

What is Empower Pharmacy's cybersecurity risk score?

Empower Pharmacy has an AI-generated cybersecurity risk score of 741 out of 1000, indicating a Moderate security posture according to Rankiteo's assessment.

How many security incidents has Empower Pharmacy experienced?

According to Rankiteo, Empower Pharmacy currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Empower Pharmacy been affected by any supply chain cyber incidents ?

According to Rankiteo, Empower Pharmacy has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Empower Pharmacy have SOC 2 Type 1 certification ?

According to Rankiteo, Empower Pharmacy is not certified under SOC 2 Type 1.

Does Empower Pharmacy have SOC 2 Type 2 certification ?

According to Rankiteo, Empower Pharmacy does not hold a SOC 2 Type 2 certification.

Does Empower Pharmacy comply with GDPR ?

According to Rankiteo, Empower Pharmacy is not listed as GDPR compliant.

Does Empower Pharmacy have PCI DSS certification ?

According to Rankiteo, Empower Pharmacy does not currently maintain PCI DSS compliance.

Does Empower Pharmacy comply with HIPAA ?

According to Rankiteo, Empower Pharmacy is not compliant with HIPAA regulations.

Does Empower Pharmacy have ISO 27001 certification ?

According to Rankiteo,Empower Pharmacy is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Empower Pharmacy operate in ?

Empower Pharmacy operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Empower Pharmacy have ?

Empower Pharmacy employs approximately 1,049 people worldwide.

Does Empower Pharmacy own any subsidiaries ?

Empower Pharmacy presently has no subsidiaries across any sectors.

How many LinkedIn followers does Empower Pharmacy have ?

Empower Pharmacy's official LinkedIn profile has approximately 27,567 followers.

What is the NAICS classification code for Empower Pharmacy ?

Empower Pharmacy is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Empower Pharmacy have a Crunchbase profile ?

Yes, Empower Pharmacy has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/empower-pharmacy.

Does Empower Pharmacy have a LinkedIn profile ?

Yes, Empower Pharmacy maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/empower-pharmacy.

How many cybersecurity incidents has Empower Pharmacy experienced ?

As of July 14, 2026, Rankiteo reports that Empower Pharmacy has experienced 1 cybersecurity incidents.

How many peer or competitor companies does Empower Pharmacy have ?

Empower Pharmacy has an estimated 5,708 peer or competitor companies worldwide.

What types of cybersecurity incidents has Empower Pharmacy faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Cyber Attack.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Empower Pharmacy

Boost Score +25 with badge (5 left)

741

/1000

Moderate

766

/1000

Fair

Empower Pharmacy Vendor Cyber Rating & Cyber Score

empowerpharmacy.com

cb in

Add Your Compliance Badge

Empower Pharmacy and Empower Pharma are transforming the landscape of compounding pharmaceuticals by delivering personalized, high-quality medication solutions at scale. As a national leader in innovation, we specialize in meeting unique patient needs with tailored medications unavailable through traditional commercial options. Whether it’s customizing dosages, eliminating allergens, or creating convenient multi-drug combinations, we’re redefining what’s possible in personalized medicine. Our vertically integrated model as a licensed manufacturer, wholesaler, and pharmacy sets us apart. By streamlining the pharmaceutical supply chain and removing unnecessary intermediaries, we offer significant cost savings without compromising quality.

Empower Pharmacy A.I CyberSecurity Scoring

Scoring History

Empower Pharmacy

Empower Pharmacy CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Empower Pharmacy

Cyber Attack

4/2026

ONENXLHYPINOOND...

Loading…

A.I.

Empower Pharmacy Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Empower Pharmacy

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Empower Pharmacy has 34.64% fewer incidents than the average of same-industry companies with at least one recorded incident.

Incidents vs All-Companies Average (This Year)

Empower Pharmacy has 4.76% fewer incidents than the average of all companies with at least one recorded incident.

Incident Types Empower Pharmacy vs Pharmaceutical Manufacturing Industry Avg (This Year)

Empower Pharmacy reported 1 incidents this year: 1 cyber attacks, 0 ransomware, 0 vulnerabilities, 0 data breaches, compared to industry peers with at least 1 incident.

Incident History - Empower Pharmacy (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Empower Pharmacy Subsidiaries

Parent Company

Empower Pharmacy

Pharmaceutical Manufacturing

Website: https://empowerpharmacy.com

Company Size: 1,001-5,000 employees

No subsidiary data available for this company.

Loading…

Empower Pharmacy Similar Companies

Glenmark Pharmaceuticals

glenmarkpharma.com

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the past four and a half decades, we have evolved from a generics company to a global organization offering specialty and branded products. Glenmark’s core values of Achievement, Respect, and Knowledge impart a sense of organizational unity that drives our growth. We have established a robust global branded generics, specialty, and OTC business; with a significant presence in the therapy areas of dermatology, respiratory, and oncology. Our ten state-of-the-art manufacturing facilities spread across four continents with operations in over 80 countries help us impact millions of patients across the globe. We recently consolidated our innovation efforts in small molecules and biologics research with the formation of ‘Ichnos Glenmark Innovation’ (IGI). This alliance is aimed at leveraging the capabilities of Glenmark and its subsidiary, Ichnos Sciences, to accelerate innovation in cancer treatment. To know more about IGI, check out: https://iginnovate.com/ Sustainability is an integral aspect of all our operations and we are focused on achieving our Environment, Social and Governance (ESG) goals. Our responsibility also extends to our communities, and over the years, our CSR efforts have touched the lives of over 3 million people.

Cipla

cipla.com

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

Fresenius Kabi

fresenius-kabi.com

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies. In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care. Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare. Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale. User information & community guidelines: https://www.fresenius-kabi.com/social-media-terms-conditions Imprint: www.fresenius-kabi.com/imprint

Lupin

lupin.com

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

Bristol Myers Squibb

cb bms.com

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html

Alkem Laboratories Ltd.

alkemlabs.com

A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did! Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of India’s largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries 32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged. We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries. Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it's Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of ‘Extended Lifecare Beyond Boundaries’.

MANKIND PHARMA LTD

mankindpharma.com

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries. Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products. Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients. Mankind strongly believes and follows its Core Values: 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: Commitment to Customer - Internal and External 𝐐𝐮𝐚𝐥𝐢𝐭𝐲: It is in our DNA to maintain and deliver highest quality standards and products 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Intensely Research driven organization aiming at product innovation and technology improvements 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Always trustworthy, widely respected to be honest, and believed by everyone 𝐆𝐨 𝐁𝐞𝐲𝐨𝐧𝐝: Aim higher than capabilities 𝐏𝐞𝐨𝐩𝐥𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧: Together we are foreseeing future and diligently stimulating our people in attaining goals

Merck Group

merckgroup.com

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a future worth living. As a family-owned company with over 350 years of experience, we stand for sustainability, responsibility, and innovative strength. We take pride in being a diverse and inclusive company that values and fosters the talents and abilities of our employees. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us. Work your Magic and join Merck. Legal Disclaimer: www.merckgroup.com/en/legal-disclaimer.html Data Privacy Declaration: www.merckgroup.com/en/privacy-statement

Loading…

NEWS

Empower Pharmacy CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

January 14, 2026 08:00 AM

Pharmacy Wields Antitrust Law In Challenge To GLP-1 Giants

Eli Lilly & Co. and Novo Nordisk are using their dominant positions in the market for weight loss and diabetes medications to squash...

Read Article

January 12, 2026 08:00 AM

XiFin Builds on Empower CareALERTS Success with New Capabilities for Pharmacy

SAN DIEGO, January 12, 2026--XiFin, Inc., a leader in revenue cycle management (RCM), including billing solutions enhanced with artificial...

Read Article

January 06, 2026 08:00 AM

Drugmakers Fight Multifront Legal Battles Over GLP-1s

In the wake of U.S. Food and Drug Administration approvals for GLP-1 weight-loss drugs, surging public demand and massive profits have...

Read Article

November 12, 2025 08:00 AM

XiFin Achieves HITRUST i1 Certification for Key Cloud-Hosted Systems, Further Strengthening Its Commitment to Cybersecurity and Data Protection

XiFin, Inc., a leader in revenue cycle management (RCM), including billing solutions enhanced with embedded artificial intelligence (AI),...

Read Article

October 11, 2025 07:00 AM

Some Cases Advance In Latest Stewart Discretionary Rulings

Deputy U.S. Patent and Trademark Office Director Coke Morgan Stewart rejected 37 Patent Trial and Appeal Board petitions Friday night,...

Read Article

August 12, 2025 07:00 AM

Empower Pharmacy Named to 2025 Inc. 5000 List of America's Fastest-Growing Companies

Empower Pharmacy, the nation's largest 503A compounding pharmacy and 503B outsourcing facility, and a trailblazer in individualized...

Read Article

July 28, 2025 07:00 AM

Eli Lilly Alleges Pharmacy Sells Knockoff Weight-Loss Drugs

Eli Lilly and Company is accusing a Houston pharmacy of selling knockoff versions of two of its Ozempic-like weight-loss drugs.

Read Article

July 09, 2025 07:00 AM

The Next Healthcare Arbitrage: PE And VC Bet On Compounding Pharmacies

Compounding pharmacies are attracting capital from private equity firms, venture capital firms, and hospitals, reshaping the pharmaceutical power dynamic from...

Read Article

July 08, 2025 07:00 AM

How Compounded GLP-1s Are Challenging Big Pharma and Drug Patents

As demand for GLP-1 drugs grows, compounding pharmacies and telehealth startups are challenging Big Pharma's grip on pricing, patents,...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-58489

SUMMARY

HedgeDoc is an open source, real-time collaborative markdown notes application. Prior to 1.11.0, the GitHub Gist export flow created an OAuth2 state value but only checked that it was present rather than validating it against the value expected for the user's session. Because the state was not properly validated, an attacker could forge a callback URL containing their own valid GitHub OAuth code. When processing the callback, HedgeDoc used the victim's logged-in session to select which note to export, but the attacker's authorization code to determine which GitHub account received it. As a result, a logged-in victim who clicked a crafted link could export their own private, protected, or limited note directly into a Gist controlled by the attacker. This issue has been fixed in version 1.11.0.

Published

Date2026-07-13

Updated

Date2026-07-13

RISK INFORMATION (Score: )

cvss4

Base Score: 6.8

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:P/PR:L/UI:A/VC:H/VI:N/VA:N/SC:H/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-58486

SUMMARY

HedgeDoc is an open source, real-time, collaborative, markdown notes application. Prior to version 1.11.0, HedgeDoc was vulnerable to a YAML alias bomb due to unsafe processing of the note frontmatter. HedgeDoc parsed frontmatter with js-yaml.load (js-yaml v3) via @hedgedoc/meta-marked, which resolved YAML anchor aliases. A compact malicious payload could therefore expand into a huge object structure, consuming excessive CPU. This expansion ran on every request to the publish view (/s/<shortid>) and, when placed under the opengraph key, the editor view (/<noteId>). A ten-level alias bomb could block the single Node.js event loop for roughly 235 seconds per request, causing concurrent requests to hang or drop and rendering the instance unavailable (DoS). Because the note was stored in the database, the impact survived process restarts until the note was removed. toobusy-js did not reliably mitigate the worst cases, as the event loop was saturated before the middleware could respond. This issue was fixed in version 1.11.0.

Published

Date2026-07-13

Updated

Date2026-07-13

RISK INFORMATION (Score: )

cvss4

Base Score: 8.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-58102

SUMMARY

Crypt::OpenSSL::X509 versions before 2.1.3 for Perl allow a heap out-of-bounds read via a long certificate extension OID in hv_exts. When building the extension hash (via extensions(), extensions_by_long_name(), extensions_by_oid(), or has_extension_oid()), the code passes OBJ_obj2txt()'s return value as the hash-key length; because that value is the OID's full text length rather than the bytes written to the fixed-size buffer (129 bytes), an OID whose text is longer than the 129-byte buffer causes a read past the allocation, exposing adjacent heap memory as the returned hash key. extensions_by_name() uses the static shortname path and is not affected.

Published

Date2026-07-13

Updated

Date2026-07-13

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-58101

SUMMARY

Crypt::OpenSSL::X509 versions before 2.1.3 for Perl allow denial of service via NULL pointer dereference. X509V3_EXT_d2i(ext) returns NULL when an extension's DER value fails to parse. basicC, ia5string, and auth_att dereference its result without a NULL check. keyid_data also dereferences akid->keyid, which is NULL for an empty AKI SEQUENCE (DER 30 00) even when the parse succeeds. A caller invoking an affected helper on an extension from an untrusted certificate triggers a SIGSEGV that crashes the Perl process.

Published

Date2026-07-13

Updated

Date2026-07-13

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-57856

SUMMARY

Cockpit CMS contains a path traversal vulnerability in the Bucket file storage API (/system/buckets/api). The api() method in modules/System/Controller/Buckets.php sanitizes the bucket name with preg_replace('/[^a-zA-Z0-9-_\\.]/','', $bucket), which permits '..' and '../' sequences. The sanitized value is interpolated into a Flysystem path as uploads://buckets/{bucket}. Flysystem's WhitespacePathNormalizer resolves 'buckets/..' to the empty string (the uploads storage root) without raising PathTraversalDetected because the '..' has a preceding component to consume. An authenticated low-privileged user can send a crafted request with a '../' bucket name to list, upload, and delete files across all buckets, including those belonging to other users or roles

Published

Date2026-07-13

Updated

Date2026-07-13

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

2.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…